{"version":"1.0","type":"link","title":"Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma.","author_name":"Lee MS 외","author_url":"https://prs-insight.online/author/Lee%20MS","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/125591","thumbnail_width":1200,"thumbnail_height":630}